Becton Dickinson/Abbott
This article was originally published in The Gray Sheet
Executive Summary
Immunological platelet analysis assay using BD's CD61 fluorescence-labeled monocolonal antibody and Abbott's Cell-Dyn 4000 hematology system will be the first product from the firms' new alliance aimed at developing novel fully automated immuno-hematology applications. The deal calls for combining Abbott's automated hematology systems with BD's flow cytometry, reagent technology and blood collection systems. Other applications in the pipeline include CD4 and CD8 count capability for the Cell-Dyn 4000